Scientists from the University of Auckland have discovered that a cancer drug called alpelisib may help extend lifespan—at ...

Pfizer Inc.’s next-generation treatment for breast cancer posted mixed results in a final-stage study, a potential setback ...

Hong Kong-listed Innovent Biologics Inc. is considering a licensing partnership to develop a cancer drug that’s showing ...

Carolyn Schutt Ibsen uses ultrasound to improve tumor targetingand tissue engineering from bioink to 3D models.

A recent study published on January 31, 2024, in Nature Aging introduces a potential new drug that could help. Scientists believe this drug can remove harmful “zombie” cells from the liver and slow ...

L’Oréal Paris has voluntarily recalled the acne treatment, La Roche-Posay Effaclar Duo acne treatment, in the United State, ...

Trial results show vepdegestrant, a protein-degrading drug Arvinas is developing with Pfizer, improved on fulvestrant in a ...

When experienced researcher Renato Aguilera happened across the chemical structure of a tried-and-true antimalarial drug one ...

Face care products from several popular brands are being recalled over elevated levels of a cancer-causing ingredient.

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.

The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

Pfizer (NYSE:PFE) stock and Arvinas (NASDAQ:ARVN) stock slip in reaction to mixed Phase 3 data for their breast cancer drug ...